1. Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial–Mesenchymal Transition
   Yu-Han Huang et al, 2023, International Journal of Molecular Sciences CrossRef
2. Transcriptomic data analysis coupled with copy number aberrations reveals a blood-based 17-gene signature for diagnosis and prognosis of patients with colorectal cancer
   Ibrahim H. Kaya et al, 2023, Frontiers in Genetics CrossRef
3. The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy
   David Standing et al, 2023, Cancers CrossRef
4. Evaluation of the Tocilizumab therapy in human cancers: Latest evidence and clinical potential
   Kimia Ghasemi et al, 2022, Journal of Clinical Pharmacy and Therapeutics CrossRef
5. TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α
   Kai Cheng et al, 2023, Journal of Interferon & Cytokine Research CrossRef
6. IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects
   Longbo Yu et al, 2024, The Journal of Immunology CrossRef
7. Cytokines as Potential Therapeutic Targets and their Role in the Diagnosis and Prediction of Cancers
   Ikenna Uchendu et al, 2023, Current Pharmaceutical Design CrossRef
8. Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
   Mansur Aliyu et al, 2022, International Immunopharmacology CrossRef
9. Effect of anti-COVID-19 drugs on patients with cancer
   Weicai Huang et al, 2024, European Journal of Medicinal Chemistry CrossRef
10. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions
    Mehrdokht Sadrkhanloo et al, 2023, Biomedicine & Pharmacotherapy CrossRef
11. Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells
    Namthip Kaewbandit et al, 2023, Scientific Reports CrossRef